USP 2232 Heavy Metals Testing Explained

USP General Chapter <2232> is the current standard for elemental impurities in dietary supplements. It replaced the old USP <231> heavy metals limit test in 2013, and the difference is not academic -- it is the difference between knowing whether toxic metals are present and guessing. USP <2232> specifies four metals of concern, establishes Permitted Daily Exposure (PDE) limits, and requires quantitative analysis by modern instrumentation (typically ICP-MS). Here is what the chapter requires, how the limits work, and what it means for your testing program.

Why USP <231> was retired and why it matters

For decades, the standard heavy metals test for supplements was USP <231>, the "heavy metals limit test." It was a colorimetric method: the sample was chemically digested and treated with thioacetamide, which produces a colored precipitate in the presence of certain metals. The analyst compared the color intensity of the sample solution to a lead standard solution and reported the result as "less than X ppm heavy metals as lead."

The problems with USP <231> were well-documented:

• It was qualitative, not quantitative. You got a pass/fail against a threshold, not actual concentrations. You never knew if your product had 0.1 ppm or 9.9 ppm of lead -- just that it was below 10 ppm (if that was your limit).
• It missed important elements. The method detected some metals but was completely insensitive to mercury and had poor recovery for arsenic and cadmium -- the most toxicologically significant elements.
• It could not produce defensible data for regulatory limits. Prop 65 limits for lead (0.5 micrograms per day, MADL) could not be evaluated with a method that only reports "less than 10 ppm."
• It was a subjective visual comparison. Two analysts could read the same sample tubes differently.

USP officially withdrew <231> and replaced it with <2232> (dietary supplements) and <2233> (drug products) in 2013. If your testing lab still offers a "heavy metals limit test," ask whether it is USP <231> or a similar colorimetric method. If it is, you are using an obsolete, withdrawn method.

⚠️ Note

Some low-cost labs still offer "heavy metals by USP <231>" because the equipment is cheap and the method is fast. Do not use it. USP <231> has been withdrawn and is not recognized by any current regulatory framework. Results from this method cannot defend your product against an FDA finding, a Prop 65 notice, or an Amazon compliance review. Always specify USP <2232> by ICP-MS for elemental impurity testing.

The four metals and their PDE limits

USP <2232> focuses on four elemental impurities that the ICH Q3D guideline and toxicological data have identified as the highest-priority toxic metals for oral exposure:

The PDE is the "permitted daily exposure" -- the maximum amount of the element that a person can be exposed to per day, for a lifetime, without appreciable health risk according to the current toxicological assessment. For a supplement label that recommends a serving size of two capsules per day, the PDE applies to two capsules per day.

Calculation example: If your product's serving size is 2 capsules per day, and ICP-MS results show lead at 2.0 mcg per serving: 2.0 mcg/day is below the PDE of 10 mcg/day. The product meets USP <2232>. If results showed lead at 12.0 mcg per serving: 12.0 mcg/day exceeds the PDE of 10 mcg/day. The product fails USP <2232>.

How PDE limits are calculated per serving

The raw analytical result from ICP-MS is typically reported as concentration in the sample -- e.g., micrograms of lead per gram of sample (mcg/g) or ppm. You must convert this to micrograms per daily serving using the actual serving mass.

Formula:

mcg/day = (element concentration in mcg/g) x (serving mass in grams) x (servings per day)

Example:

Your supplement has a serving size of 2 capsules (total 1.5 g per serving) and the label recommends 2 servings per day (3.0 g total daily dose). The lab reports lead at 2.0 mcg/g in the finished product.

Daily exposure = 2.0 mcg/g x 1.5 g/serving x 2 servings/day = 6.0 mcg lead/day.

This is below the PDE of 10 mcg/day. The product passes USP <2232> for lead.

The same calculation applies to arsenic, cadmium, and mercury. If any single element exceeds its PDE, the product fails USP <2232>.

For a deeper dive on heavy metals testing in the broader regulatory context, see our heavy metal testing guide.

ICP-MS: the method of choice

USP <2232> specifies that elemental impurities should be determined by a procedure validated for accuracy, precision, and specificity. The chapter references USP <233>, which describes two instrumental procedures: ICP-MS (Inductively Coupled Plasma Mass Spectrometry) and ICP-OES (Inductively Coupled Plasma Optical Emission Spectroscopy).

ICP-MS is the method of choice for dietary supplements because:

• Detection limits: ICP-MS can detect elements at sub-part-per-billion (ppb) levels, which is essential for evaluating Prop 65 lead limits (0.5 mcg/day MADL) and for products with low daily serving sizes where trace concentrations matter.
• Multi-element capability: ICP-MS measures all four elements (plus others if needed: chromium, nickel, cobalt, etc.) in a single analytical run, reducing cost and turnaround time.
• Wide dynamic range: Elements can be measured from sub-ppb to high ppm levels in the same run, accommodating both trace toxic elements and nutritional mineral levels.

ICP-OES can also be used but has higher detection limits (typically low-to-mid ppb range rather than sub-ppb). For products with a large daily serving size and lead levels comfortably below PDE, ICP-OES may be sufficient. For products with small serving sizes, low target PDE levels, or when Prop 65 compliance is a concern, ICP-MS is the standard.

The complete analytical workflow:

1. Sample preparation: Microwave-assisted acid digestion using nitric acid (and sometimes hydrochloric acid) to dissolve the sample matrix and liberate elemental impurities into solution. This is the most critical step -- incomplete digestion gives falsely low results.
2. Calibration: Multi-element calibration standards traceable to NIST reference materials. Internal standards (typically yttrium, indium, or rhodium) are added to correct for instrumental drift and matrix effects.
3. Analysis: The sample solution is introduced into the ICP-MS, where the plasma ionizes the elements and the mass spectrometer separates and quantifies them by mass-to-charge ratio.
4. Quality control: Every analytical batch includes blank, duplicate, spike recovery, and certified reference material (CRM) samples. Spike recoveries must fall within 80-120%. CRM results must fall within certified ranges.
5. Result calculation and PDE evaluation: Lab reports concentration per sample; manufacturer calculates mcg/day and compares to PDE limits.

Sample requirements for USP <2232> testing

The sample requirements are modest but specific:

• Sample quantity: 5-10 g or 10-20 capsules/tablets. The lab needs enough material for acid digestion and replicate analysis.
• Sample form: Finished product in final packaging is ideal. The consumer-relevant form is what matters.
• Sample preparation for unusual matrices: Gummies, liquids, softgels, and high-fat products may require modified digestion procedures. Inform the lab of your matrix type when requesting a quote.
• Reporting limit: Specify that you need detection limits low enough to evaluate against the PDE (and Prop 65 if applicable). A lab that reports "< 1 ppm" for lead when you need to evaluate against 10 mcg/day with a small serving size may not have adequate sensitivity.
• Speciation: If total arsenic results approach the PDE (e.g., total arsenic at 12 mcg/day), speciation analysis to distinguish inorganic arsenic from organic arsenic (which is less toxic) may be warranted. Arsenic speciation typically uses HPLC-ICP-MS and is an additional cost.

Prop 65 and USP <2232>

California Proposition 65 (Prop 65) sets much lower limits than USP <2232> for certain elements, particularly lead. The Prop 65 Maximum Allowable Dose Level (MADL) for lead is 0.5 mcg/day -- twenty times lower than the USP <2232> PDE of 10 mcg/day.

A product can pass USP <2232> and fail Prop 65. This is intentional: USP <2232> sets health-protective limits based on lifetime exposure risk assessment, while Prop 65 is a right-to-know warning statute with limits that incorporate a significant safety margin below the no-observable-effect level.

If you sell in California (which effectively means selling anywhere in the US given online commerce), you must test for lead at detection limits that allow evaluation against 0.5 mcg/day. Many labs can achieve sub-0.5 mcg/day detection with ICP-MS, but you must specifically request Prop 65-sensitive reporting limits when submitting samples.

For more context on regulatory testing frameworks, see our 21 CFR 111 testing requirements.

Quick Reference

Lab Category Matching

Real Methods Explained

What Sample to Send

5-10 g of finished product in final packaging or 10-20 capsules/tablets. For products with unusual matrices (gummies, liquids, softgels, high-fat powders), notify the lab before shipping. The lab may require a different sample quantity or preparation procedure. Chain-of-custody documentation is recommended if results are for regulatory or compliance use.

Expected Turnaround Time

Accreditation Notes

Ensure the lab's ISO/IEC 17025 scope of accreditation specifically includes ICP-MS or ICP-OES for elemental analysis in dietary supplements or food matrices. The scope should reference USP <2232> or at minimum elemental impurity testing by USP <233>. A lab accredited for ICP-MS in water or environmental samples may not have validated the method for dietary supplement matrices, which have very different digestion challenges (e.g., high mineral content, organic binders, lipid matrices). Matrix-specific validation is part of accreditation scope.

Price Ranges

Country/Region Targeting

USP <2232> is a US Pharmacopeia standard recognized primarily for products marketed in the US. The ICH Q3D guideline (used for pharmaceuticals) influenced USP <2232> development, and the same four metals with similar PDEs are common internationally. For products exported to the EU, the EU Regulation 1881/2006 sets maximum levels for lead, cadmium, mercury, and inorganic arsenic in food supplements. EU limits may differ from USP <2232> PDEs. For products exported to California, Prop 65 requirements (especially lead MADL of 0.5 mcg/day) are more stringent than USP <2232> PDEs. Always verify the specific regulatory limits for each target market.

FAQ

Q: What is the difference between USP <231> and USP <2232>?

USP <231> was the old colorimetric heavy metals limit test. It was qualitative (pass/fail against a threshold), insensitive to mercury, had poor recovery for arsenic and cadmium, was subjective (visual color comparison), and was officially withdrawn by USP in 2013. USP <2232> is the current standard. It specifies four metals (lead, arsenic, cadmium, mercury), sets PDE limits per daily serving, and requires quantitative instrumental analysis (ICP-MS or ICP-OES). The difference is substantial: <231> told you whether your product was below a crude threshold. <2232> tells you exactly how much of each metal is present and whether each metal individually meets its PDE. Every supplement testing program should use USP <2232>, not the withdrawn USP <231>.

Q: How do I calculate whether my product passes USP <2232>?

Take the concentration of each element from the lab report (typically in mcg/g or ppm). Multiply by the serving mass in grams to get mcg per serving. Then multiply by the number of servings recommended per day on your label. Compare the result to the PDE: lead 10 mcg/day, arsenic 15 mcg/day, cadmium 5 mcg/day, mercury 15 mcg/day. If any element exceeds its PDE, the product fails USP <2232>. The calculation must use the maximum recommended daily serving, not the minimum. If your label says "1-2 capsules daily," use 2 capsules for the calculation. The lab report generally provides concentration only; it is your responsibility to calculate mcg/day and evaluate against PDEs.

Q: Do I need to test for heavy metals on every batch?

21 CFR 111.75(a)(2) requires finished product testing to verify specifications are met. If your specification includes heavy metals limits (which it should), then heavy metals testing is part of required finished product testing. Some manufacturers use skip-lot testing where a subset of batches is tested for heavy metals based on a risk-based frequency. However, given the safety significance of heavy metals and the relatively low cost of ICP-MS testing, batch-level testing is the conservative and recommended approach. For more guidance on testing frequency, see our supplement testing cost guide.

Q: Why does Prop 65 have a lower lead limit than USP <2232>?

Prop 65's Maximum Allowable Dose Level (MADL) for lead is 0.5 mcg/day, while the USP <2232> PDE for lead is 10 mcg/day. The difference is driven by the different legal frameworks. Prop 65 is a right-to-know statute that requires warnings if exposure exceeds the MADL, which is set by dividing the no-observable-effect level (NOEL) by a safety factor of 1,000. USP <2232> PDEs are derived through ICH Q3D toxicological risk assessment methodology, which uses modifying factors rather than a fixed 1,000x safety margin. The result is that Prop 65 thresholds are substantially lower than USP PDEs. A product can pass USP <2232> and still require a Prop 65 warning in California. From a commercial perspective, many brands test to Prop 65 levels to avoid the warning requirement entirely, even if USP <2232> is the formal compliance standard.

Q: What if my product's total arsenic exceeds the PDE but most of it is organic arsenic?

The USP <2232> PDE of 15 mcg/day applies to inorganic arsenic, which is the toxicologically significant form. Total arsenic measured by ICP-MS includes both inorganic and organic arsenic. If total arsenic approaches or exceeds the PDE, speciation analysis should be performed to determine the inorganic arsenic fraction. Organic arsenic (primarily arsenobetaine, arsenosugars, and other organic species) is significantly less toxic and is not counted toward the PDE. If speciation shows that inorganic arsenic is well below the PDE, the product passes USP <2232> even if total arsenic is above 15 mcg/day. Arsenic speciation requires HPLC-ICP-MS and typically takes longer and costs more than total arsenic analysis. Do not assume high total arsenic is benign organic arsenic -- verify by speciation.

Get lab testing quotes →